Skip to content
CancerIndex

Loading the knowledge graph…

Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency — knowledge graph · CancerIndex